Position in NVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,221,475
+$21,013 QoQ
Shares Held
7,794
-0.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#180
of 649 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $26,573,081 across 16 Drug Manufacturers - General names. NVS ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,036 | $6,040,329 | |
| 2 | MRK |
Merck & Co., Inc.
|
44,957 | $5,776,974 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
30,848 | $3,897,336 | |
| 4 | AMGN |
Amgen Inc
|
10,266 | $3,717,523 | |
| 5 | AZN |
Astrazeneca PLC
|
13,217 | $2,506,207 | |
| 6 | ABBV |
AbbVie Inc.
|
5,759 | $1,449,194 | |
| 7 | NVS |
Novartis AG
This page
|
7,794 | $1,221,475 | |
| 8 | JNJ |
Johnson & Johnson
|
3,962 | $1,006,229 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,221,475 | 7,794 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,200,462 | 7,859 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,087,656 | 7,889 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,011,044 | 7,884 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $972,073 | 8,033 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $985,706 | 8,842 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $890,580 | 9,152 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,131,451 | 9,837 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,787,888 | 16,794 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,658,435 | 17,145 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,761,825 | 17,449 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $1,848,656 | 18,149 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,944,232 | 19,267 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,865,392 | 20,276 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $1,883,347 | 20,760 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $1,609,815 | 21,179 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,804,292 | 21,345 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,855,386 | 21,144 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $1,855,151 | 21,209 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,765,057 | 21,583 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,977,900 | 21,678 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,867,139 | 21,843 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $2,097,290 | 22,210 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,981,383 | 22,785 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,083,059 | 23,850 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,056,632 | 24,944 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||